Social media

ICON’s cardio-metabolic drug development experts are attending the Global CVCT Forum on 8-10 December. Arrange a time to speak with our experts to learn how we support clinical trials across multiple indications, includi...

Antimicrobial resistance (AMR) is a pressing global health and socioeconomic crisis. In the past 5 years, ICON has participated in 400+ infectious disease clinical studies enrolling 483,200+ patients and healthy voluntee...

PLATO is a publicly available, 11-item PRO measure designed to monitor treatment response and symptom progression in adults with obstructive sleep apnea. It’s quick to complete (under 4 minutes), reliable, and validated ...

What does a successful digital endpoint look like? In Duchenne muscular dystrophy trials, stride velocity 95th percentile (SV95C) replaced the 6-minute walk test (6MWT) and secured EMA approval. This case study is a po...

Biotech and pharma sponsors need agile, scalable clinical trial monitoring. Our latest whitepaper explores how decentralised and risk-based models are improving efficiency and site performance. Read more: https://www.i...

Biotech and pharma sponsors need agile, scalable clinical trial monitoring. Our latest whitepaper explores how decentralised and risk-based models are improving efficiency and site performance. Read more: https://lnkd....

Accelerate Your Insights with Symphony FLEX™ Looking for a fast-turn, high-impact investment before year-end? FLEX gives you access to ~300M patient-level records, now with: • Medical payer & remittance data • Snowflake...

As you plan your remaining 2025 budget, consider a solution that accelerates insights across industries: Symphony FLEX™ from Symphony Health, an ICON plc company. FLEX provides market-agnostic, longitudinal patient-leve...

What motivates someone to stay in clinical research for over 20 years? For Victoria DeVeaugh-Geiss, Director of Clinical Operations at ICON, it comes down to one thing: knowing that her work helps bring treatments to pa...

What motivates someone to stay in clinical research for over 20 years? For Victoria DeVeaugh Geiss, Director of Clinical Operations at ICON, it comes down to one thing: knowing that her work helps bring treatments to pa...

70% of clinical research sites report a rise in study execution burden. Yet, when investigators enjoy a superior sponsor experience, they may enrol twice as many patients. Join our live webinar on 3 December at 10am ET ...

70% of clinical research sites report a rise in study execution burden. Yet, when investigators enjoy a superior sponsor experience, they may enrol twice as many patients. Join our live webinar on 3 December at 10am ET ...